Exciting news! A captivating interview with our co-founders Jenny Prange and Deana Mohr following the prestigious “Female innovator award 2023”. Their insights and stories are sure to inspire. Check it out!

Zurich, Switzerland, September 25, 2023 – MUVON Therapeutics, a leading Swiss biotech startup, is advancing a minimally-invasive personalized tissue-engineered regenerative therapy for female urinary incontinence. During Urology Week (24-30 September), MUVON Therapeutics joins the European Association of Urology (EAU) and supports their Urge to Act campaign focused on making policymakers aware that there are novel approaches under investigation to improve continence health

MUVON's co-founders Deana Mohr and Jenny Prange received the Female Innovator of the year Award at the 6th Female Innovation Forum . A jury consisting of 24 members selected MUVON's two co-founders from a long-list of 60 nominees in recognition of their efforts over the past years to bring MUVON's innovative regenerative therapy from the lab into the clinics in order to provide women suffering from stress urinary incontinence access to an affordable, low risk & potentially cu